Chao-Wu Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Chao-Wu Liu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Chun-Hui He
Guangzhou Women and Children’s Medical Center, Guangzhou, 510120 Guangdong, China
1 shared publication - Deguang Yang
Department of Cardiology the First Affiliated Hospital of Jinan University Guangzhou China
1 shared publication - Gen-Quan Yin
Guangzhou Women and Children’s Medical Center, Guangzhou, 510120 Guangdong, China
1 shared publication - Hong Wang
Guangdong Province Engineering Research Center for Antibody Drug and Immunoassay, College of Life Science and Technology, Jinan University, Guangzhou, Guangdong, China
1 shared publication - Hong-Ling Jia
Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou, 510632, Guangdong, China
1 shared publication - Li Deng
Guangzhou Women and Children's Medical Center, Guangzhou 510120, Guangdong, China
1 shared publication
Latest Publications
- 11 February 2025
- Published by Springer Nature in Acta Diabetologica
- Vol. 62 (9) , 1417-1428
Identify of blood glucose metabolism regulation pathways and related proteins in the db/db mouse model through iTRAQ quantitative mass spectrometry
Background Diabetes cardiomyopathy (DCM) has become the main cause of death of diabetes patients due to heart failure. As the initial unclear symptoms and complex underlying pathological mechanisms, it presents significant challenges for early diagnosis. It is essential to explore valuable biomarkers to enhance our understanding involved in DCM. Methods Twelve-week-old db/db model mice (diabetes group) and normal mice (control group) were maintained in a specific pathogen-free (SPF) environment. Body weight, blood glucose, and insulin levels were measured regularly. At 26 weeks, cardiac tissue was collected to assess oxidative stress, inflammatory factors, and fibrosis markers, followed by histopathological examination. Meanwhile, iTRAQ-based quantitative mass spectrometry was employed to identify differentially expressed proteins (DEPs) in cardiac tissue. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) methods were utilized to analyze their biological functions and signaling pathways. Furthermore, specific proteins and their associated signaling pathways related to blood glucose regulation were validated in cardiac tissue and myocardial cells using western blot and immunofluorescence analysis. Results The mice in the control group were active and exhibited healthy growth, whereas those in the diabetes group showed increased food and water intake. Furthermore, there were significant elevations in blood glucose concentration, insulin levels, and body weight in the diabetes group. Histopathological examinations revealed that the myocardium in the diabetes group was markedly hypertrophic due to persistent hyperglycemia, accompanied by muscle fiber disarray, nuclear damage, and a significant increase in the expression of oxidative stress and inflammatory factors. Mass spectrometry analysis identified a total of 107 DEPs, comprising 83 up-regulated and 24 down-regulated proteins. Notably, the most significant difference was observed in the regulation of the glycogen metabolism enzyme (PYGM). GO and KEGG analyses indicated that the DEPs were primarily involved in glycogen metabolism, catalysis, and oxidative stress, with signaling pathways related to fatty acid metabolism, the PPAR pathway, insulin resistance, and the tricarboxylic acid cycle. Subsequent immunofluorescence and western blot analysis confirmed that hyperglycemia inhibits the PI3K/AKT signaling pathway and upregulates the expression of PYGM. Conversely, the knockout of PYGM significantly enhanced the activity of the PI3K/AKT signaling pathway. Conclusion The research suggests that the inhibition of PYGM enhances the activity of the PI3K/AKT signaling pathway in patients with DCM, and then help to reduce blood glucose levels. This molecular mechanism exerts a protective effect on DCM. These findings highlight the potential of targeting PYGM as a novel biomarker for the early diagnosis, which may serve as an effective therapeutic strategy.
- 11 February 2025
- Published by Springer Nature in Acta Diabetologica
- Vol. 62 (9) , 1417-1428
Identify of blood glucose metabolism regulation pathways and related proteins in the db/db mouse model through iTRAQ quantitative mass spectrometry
Background Diabetes cardiomyopathy (DCM) has become the main cause of death of diabetes patients due to heart failure. As the initial unclear symptoms and complex underlying pathological mechanisms, it presents significant challenges for early diagnosis. It is essential to explore valuable biomarkers to enhance our understanding involved in DCM. Methods Twelve-week-old db/db model mice (diabetes group) and normal mice (control group) were maintained in a specific pathogen-free (SPF) environment. Body weight, blood glucose, and insulin levels were measured regularly. At 26 weeks, cardiac tissue was collected to assess oxidative stress, inflammatory factors, and fibrosis markers, followed by histopathological examination. Meanwhile, iTRAQ-based quantitative mass spectrometry was employed to identify differentially expressed proteins (DEPs) in cardiac tissue. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) methods were utilized to analyze their biological functions and signaling pathways. Furthermore, specific proteins and their associated signaling pathways related to blood glucose regulation were validated in cardiac tissue and myocardial cells using western blot and immunofluorescence analysis. Results The mice in the control group were active and exhibited healthy growth, whereas those in the diabetes group showed increased food and water intake. Furthermore, there were significant elevations in blood glucose concentration, insulin levels, and body weight in the diabetes group. Histopathological examinations revealed that the myocardium in the diabetes group was markedly hypertrophic due to persistent hyperglycemia, accompanied by muscle fiber disarray, nuclear damage, and a significant increase in the expression of oxidative stress and inflammatory factors. Mass spectrometry analysis identified a total of 107 DEPs, comprising 83 up-regulated and 24 down-regulated proteins. Notably, the most significant difference was observed in the regulation of the glycogen metabolism enzyme (PYGM). GO and KEGG analyses indicated that the DEPs were primarily involved in glycogen metabolism, catalysis, and oxidative stress, with signaling pathways related to fatty acid metabolism, the PPAR pathway, insulin resistance, and the tricarboxylic acid cycle. Subsequent immunofluorescence and western blot analysis confirmed that hyperglycemia inhibits the PI3K/AKT signaling pathway and upregulates the expression of PYGM. Conversely, the knockout of PYGM significantly enhanced the activity of the PI3K/AKT signaling pathway. Conclusion The research suggests that the inhibition of PYGM enhances the activity of the PI3K/AKT signaling pathway in patients with DCM, and then help to reduce blood glucose levels. This molecular mechanism exerts a protective effect on DCM. These findings highlight the potential of targeting PYGM as a novel biomarker for the early diagnosis, which may serve as an effective therapeutic strategy.
- Open Access
- 17 September 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 506
MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease
Changes of miRNAs in exosome have been reported in different disease diagnosis and provided as potential biomarkers. In this study, we compared microRNA profile in exosomes in 5 MHFMD and 5 ESHFMD as well as in 5 healthy children. Different expression of miRNAs in exosomes across all the three groups were screened using miRNA microarray method. Further validated test was conducted through quantitative real-time PCR assays with 54 exosome samples (18 ESHFMD, 18 MHFMD, and 18 healthy control). The judgment accuracy was then estimated by the receiver operating characteristic (ROC) curve analysis; and the specificity and sensitivity were evaluated by the multiple logistic regression analysis. There were 11 different miRNAs in exosomes of MHFMD and ESHFMD compared to healthy children, of which 4 were up-regulated and 7 were down-regulated. Further validation indicated that the 4 significant differentially expressed candidate miRNAs (miR-671-5p, miR-16-5p, miR-150-3p, and miR-4281) in exosome showed the same changes as in the microarray analysis, and the expression level of three miRNAs (miR-671-5p, miR-16-5p, and miR-150-3p) were significantly different between MHFMD or ESHFMD and the healthy controls. The accuracy of the test results were high with the under curve (AUC) value range from 0.79 to 1.00. They also provided a specificity of 72%-100% and a sensitivity of 78%-100%, which possessed ability to discriminate ESHFMD from MHFMD with the AUC value of 0.76-0.82. This study indicated that the exosomal miRNA from patients with different condition of HFMD express unique miRNA profiles. Exosomal miRNA expression profiles may provide supplemental biomarkers for diagnosing and subtyping HFMD infections.
- 17 September 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 506
Open AccessMicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease
Changes of miRNAs in exosome have been reported in different disease diagnosis and provided as potential biomarkers. In this study, we compared microRNA profile in exosomes in 5 MHFMD and 5 ESHFMD as well as in 5 healthy children. Different expression of miRNAs in exosomes across all the three groups were screened using miRNA microarray method. Further validated test was conducted through quantitative real-time PCR assays with 54 exosome samples (18 ESHFMD, 18 MHFMD, and 18 healthy control). The judgment accuracy was then estimated by the receiver operating characteristic (ROC) curve analysis; and the specificity and sensitivity were evaluated by the multiple logistic regression analysis. There were 11 different miRNAs in exosomes of MHFMD and ESHFMD compared to healthy children, of which 4 were up-regulated and 7 were down-regulated. Further validation indicated that the 4 significant differentially expressed candidate miRNAs (miR-671-5p, miR-16-5p, miR-150-3p, and miR-4281) in exosome showed the same changes as in the microarray analysis, and the expression level of three miRNAs (miR-671-5p, miR-16-5p, and miR-150-3p) were significantly different between MHFMD or ESHFMD and the healthy controls. The accuracy of the test results were high with the under curve (AUC) value range from 0.79 to 1.00. They also provided a specificity of 72%-100% and a sensitivity of 78%-100%, which possessed ability to discriminate ESHFMD from MHFMD with the AUC value of 0.76-0.82. This study indicated that the exosomal miRNA from patients with different condition of HFMD express unique miRNA profiles. Exosomal miRNA expression profiles may provide supplemental biomarkers for diagnosing and subtyping HFMD infections.